Pulse Biosciences
PLSE
62 hedge funds and large institutions have $41.5M invested in Pulse Biosciences in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
105% more call options, than puts
Call options by funds: $2.42M | Put options by funds: $1.18M
24% more funds holding
Funds holding: 50 → 62 (+12)
0.57% more ownership
Funds ownership: 8.1% → 8.67% (+0.57%)
23% less capital invested
Capital invested by funds: $53.9M → $41.5M (-$12.4M)
58% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.74M |
| 2 |
Renaissance Technologies
New York
|
+$564K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$463K |
| 4 |
Millennium Management
New York
|
+$380K |
| 5 |
GAM
Griffin Asset Management
New York
|
+$374K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$495K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$323K |
| 3 |
BlackRock
New York
|
-$248K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$200K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$129K |
PLSE Hedge Fund Activity: Q1 2024 in Review
62 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2024, worth a combined $41.5M — down 23% from $53.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PLSE positions and 3 closed out — a net gain of 12 holders — while 10 added to existing stakes and 24 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.74M. The largest seller was Morgan Stanley, cutting an estimated $495K.
- 62 institutional investors held Pulse Biosciences (PLSE) as of Q1 2024, up from 50 in Q4 2023.
- Funds reported $41.5M of Pulse Biosciences stock for Q1 2024, down 23% quarter-over-quarter.
- 15 funds opened new Pulse Biosciences positions in Q1 2024 and 3 closed out, a net change of +12 holders.
- The largest Pulse Biosciences buyer in Q1 2024 was Vanguard Group, an estimated $1.74M added.
- The largest Pulse Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $495K sold.
Based on aggregated 13F filings for Q1 2024.